Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
Conditions:   Oligometastatic Disease;   Liver Metastases;   Colorectal Cancer
Interventions:   Drug: Gadoxetate disodium;   Drug: Gadobenate dimeglumine
Sponsors:   University of Colorado, Denver;   Bracco Diagnostics, Inc;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 28, 2021Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments